Changing the Paradigm of HLA Typing: Better Matching, Better Method
CareDx Pre-transplant Lunch Symposium
Nicholas Brown, University of Pennsylvania, USA
Reduced PCR-Induced Errors from a Hybrid Capture-Based NGS Assay for HLA Typing
Nils Lachhman, Charité-Universitätsmedizin, Berlin, Germany
Significance of High Resolution HLA Typing in Solid Organ Transplantation
Eric Spierings, University Medical Center Utrecht, Netherlands
Allelic typing for Epitope Matching in Transplantation
Revolutionizing Post-Transplant Monitoring: Better Outcomes start with Better Surveillance
CareDx Post-transplant Lunch Symposium
Caner Süsal, University of Heidelberg, Germany
Donor-Derived Cell-Free DNA as Biomarker to Assess Active Rejection & Treatment Response in Kidney Allografts
Maria Generosa Crespo-Leiro, Complexo Hospitalario Universitario A Coruña (CHUAC), Spain
Value of dd-cfDNA as a Surveillance Biomarker in Heart Transplant
Mathilde Cherel, EFS Rennes, Blood bank of Brittany, France
Quality Approach and Adoption of NGS based Chimerism solution in a French Laboratory
CareDx Virtual Sessions
Friday, April 23 12:30-1:30 PM BST: Curtis Lind – Director, Market Development, CareDx
HCT – The Latest Innovation in NGS-based Chimerism Testing
Wednesday, Apr 21, 12-1 PM BST: Carla Wirtz – Transplant Application Specialist, CareDx
AlloSeq Tx17 improvements and AlloSeq Assign: Software Demo and Analysis
CareDx Posters at EFI – A Review Session
Thursday, April 22
The CareDx team will present 6 posters on pre-transplant HLA matching innovation.